179 related articles for article (PubMed ID: 31088937)
1. Pathological review of primary cutaneous malignant melanoma by a specialist skin cancer multidisciplinary team improves patient care in the UK.
Bhoyrul B; Brent G; Elliott F; McLorinan J; Wilson A; Peach H; Mathew B; Mitra A
J Clin Pathol; 2019 Jul; 72(7):482-486. PubMed ID: 31088937
[TBL] [Abstract][Full Text] [Related]
2. A critical review of melanoma pathology reports for patients referred to the Western Australian Melanoma Advisory Service.
Monshizadeh L; Hanikeri M; Beer TW; Heenan PJ
Pathology; 2012 Aug; 44(5):441-7. PubMed ID: 22772338
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases.
Niebling MG; Haydu LE; Karim RZ; Thompson JF; Scolyer RA
Ann Surg Oncol; 2013 Nov; 20(12):3969-75. PubMed ID: 23851608
[TBL] [Abstract][Full Text] [Related]
4. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
[TBL] [Abstract][Full Text] [Related]
5. Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications.
Patrawala S; Maley A; Greskovich C; Stuart L; Parker D; Swerlick R; Stoff B
J Am Acad Dermatol; 2016 Jan; 74(1):75-80. PubMed ID: 26514601
[TBL] [Abstract][Full Text] [Related]
6. A second expert pathology review of cutaneous melanoma in multidisciplinary meetings: Impact on treatment decisions.
Palve JS; Ylitalo LK; Luukkaala TH; Jernman JM; Korhonen NJ
Surg Oncol; 2019 Sep; 30():72-75. PubMed ID: 31500789
[TBL] [Abstract][Full Text] [Related]
7. Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management.
Eriksson H; Frohm-Nilsson M; Hedblad MA; Hellborg H; Kanter-Lewensohn L; Krawiec K; Lundh Rozell B; Månsson-Brahme E; Hansson J
Acta Derm Venereol; 2013 Jul; 93(4):411-6. PubMed ID: 23306667
[TBL] [Abstract][Full Text] [Related]
8. Influence of variability in assessment of Breslow thickness, mitotic rate and ulceration among US pathologists interpreting invasive melanoma, for the purpose of AJCC staging.
Taylor L; Hood K; Reisch L; Elmore J; Piepkorn M; Barnhill R; Knezevich S; Radick A; Elder D
J Cutan Pathol; 2018 Aug; 45(8):588-596. PubMed ID: 29717800
[TBL] [Abstract][Full Text] [Related]
9. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.
Busam KJ; Antonescu CR; Marghoob AA; Nehal KS; Sachs DL; Shia J; Berwick M
Am J Clin Pathol; 2001 Jun; 115(6):856-60. PubMed ID: 11392882
[TBL] [Abstract][Full Text] [Related]
10. Global and mitosis-specific interobserver variation in mitotic count scoring and implications for malignant melanoma staging.
Saldanha G; Ali R; Bakshi A; Basiouni A; Bishop R; Colloby P; Craig P; Da Forno P; Edward S; Espinosa de Los Monteros O; Evans A; Jamieson L; Rytina E; Bamford M
Histopathology; 2020 May; 76(6):803-813. PubMed ID: 31879972
[TBL] [Abstract][Full Text] [Related]
11. Inter-observer variation in the histopathology reports of head and neck melanoma; a comparison between the seventh and eighth edition of the AJCC staging system.
Berger DMS; Wassenberg RM; Jóźwiak K; van de Wiel BA; Balm AJM; van den Berg JG; Klop WMC
Eur J Surg Oncol; 2019 Feb; 45(2):235-241. PubMed ID: 30385156
[TBL] [Abstract][Full Text] [Related]
12. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
Busam KJ
Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
[TBL] [Abstract][Full Text] [Related]
13. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
Shoo BA; Sagebiel RW; Kashani-Sabet M
J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612
[TBL] [Abstract][Full Text] [Related]
14. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care.
Keung EZ; Gershenwald JE
Expert Rev Anticancer Ther; 2018 Aug; 18(8):775-784. PubMed ID: 29923435
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
16. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract][Full Text] [Related]
17. Does staging computered tomography change management in thick malignant melanoma?
Sawyer A; McGoldrick RB; Mackey SP; Allan R; Powell B
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):453-6. PubMed ID: 18468970
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.
Corona R; Mele A; Amini M; De Rosa G; Coppola G; Piccardi P; Fucci M; Pasquini P; Faraggiana T
J Clin Oncol; 1996 Apr; 14(4):1218-23. PubMed ID: 8648377
[TBL] [Abstract][Full Text] [Related]
19. Thin Melanoma: A Generic Term Including Four Histological Subtypes of Cutaneous Melanoma.
Roncati L; Pusiol T; Piscioli F
Acta Dermatovenerol Croat; 2016 Dec; 24(4):169-174. PubMed ID: 28128089
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?
Taylor LA; Eguchi MM; Reisch LM; Radick AC; Shucard H; Kerr KF; Piepkorn MW; Knezevich SR; Elder DE; Barnhill RL; Elmore JG
Cancer; 2021 Sep; 127(17):3125-3136. PubMed ID: 33945628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
